Omnicell, Inc. (OMCL)

Pharmacy automation devices, software and service. Read November 8, 2026 from the annual report for the period ending December 31, 2025, filed February 26, 2026. Ranked 38 of the 145 Healthcare companies read so far, by the share within reach now.

Omnicell states about 3,580 employees, 3,140 in the United States or Canada, making medication dispensing automation read at medical equipment manufacturing, with its software at software publishers and its technical services at precision equipment repair, by description.

The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.

What follows from the reading

Share of working time within reach of AI, on the long-run pace at four in five: 36% now, 45% at the end of 2027, 48% at the end of 2028, 48% at the end of 2030. By the patterns, the work is about 48% desk work, 17% people work and 34% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 49% of the working time stays with people (conversation, in-person and hands-on work), 42% becomes checking a model's work and 8% could be handed over with lighter checks, from the industries' own figures, not the company's roles.

Headcount

3,580 employees as of December 31, 2025 (stated). About 3,140 of 3,580 employees are in the United States or Canada; the United States is not stated apart, so the share stays null; the data service shows 90% of revenue in the United States.

The filing: “As of December 31, 2025, we had approximately 3,580 employees worldwide (with approximately 3,140 located in either the United States or Canada), excluding individuals who are classified as temporary or contractors.”

The workforce as industry patterns

What the filing says about the workforce: About 3,580 full-time employees worldwide, 3,140 in the United States or Canada, temporary workers and contractors excluded; the count has fallen from 4,230 in 2022; employee satisfaction score 74 on the annual survey.

Companies read with the same leading pattern

Other companies whose largest staffing pattern is also Medical Equipment and Supplies Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five. Now is projected from METR's April 2026 measurement and Epoch's November 2026 index.

• Abbott Laboratories (ABT, 115,000 employees)28% now, 37% by 2028
• Becton, Dickinson and Company (BDX, 72,000 employees)29% now, 38% by 2028
• Boston Scientific Corporation (BSX, 59,000 employees)32% now, 44% by 2028
• Stryker Corporation (SYK, 56,000 employees)30% now, 41% by 2028
• Baxter International Inc. (BAX, 37,500 employees)30% now, 39% by 2028
• Align Technology, Inc. (ALGN, 20,290 employees)29% now, 38% by 2028
• Solventum Corporation (SOLV, 20,000 employees)33% now, 45% by 2028
• STERIS plc (STE, 17,937 employees)33% now, 41% by 2028

What the filing says about AI

26 sentences in the filing name AI. The filing names AI mainly in its regulatory discussion, the evolving landscape of AI laws including over 1,080 state bills introduced in 2025, and in its risk factors, in 26 sentences.

• “The following risks related to our business, among others, could cause actual results to differ materially from those described in the forward-looking statements: unfavorable general economic and market conditions, including the potential impact of inflationary pressures; our ability to take advantage of growth opportunities and develop and commercialize new solutions and enhance existing solut...”
• “The Rule imposes stringent obligations on companies within its scope and prohibits or restricts "covered data transactions" that grant countries of concern or covered persons access to bulk U.S. sensitive personal data or any amount of "government-related data." Artificial Intelligence (AI) The regulatory landscape governing data, digital services, and artificial intelligence continues to evolv...”
• “In the U.S., during the 2025 legislative session, over 1,080 AI-related bills were introduced across U.S. state legislatures, resulting in approximately 100 enacted measures across 38 jurisdictions addressing AI-generated content labeling, whistleblower protections, transparency requirements, and intellectual property protections.”
• “This legislative activity builds upon the 99 AI-specific laws enacted in 2024 and 18 resolutions adopted in 2023, reflecting sustained momentum in AI regulation at the state level.”
• “At the international level, the European Union AI Act entered into force with key provisions becoming applicable in 2025, including prohibitions on certain high-risk AI systems and compliance obligations for general-purpose AI models.”

Its annual reports, year by year

Sentences naming AI in each annual report, counted by one rule, beside the median report in the Index that year. Each count links its filing. Every company, by year and sector

• Fiscal 20210median 0
• Fiscal 20220median 0
• Fiscal 20239median 1
• Fiscal 202422median 4
• Fiscal 202526median 10

Headcount by filing year

As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.

Limits of this reading

• The three-way split is by description (c); the filing counts no employees by function, and its segment table shows revenue types.
• The U.S. share is not stated apart from Canada.

Source: the company's annual report on EDGAR, accession 0000926326-26-000006, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.